Baltimore-Washington Financial Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-20,502
| Closed | -$486K | – | 139 |
|
|
2020
Q2 | $486K | Sell |
20,502
-625
| -3% | -$14.8K | 0.07% | 90 |
|
|
2020
Q1 | $380K | Sell |
21,127
-8,723
| -29% | -$157K | 0.07% | 95 |
|
|
2019
Q4 | $708K | Sell |
29,850
-9,173
| -24% | -$218K | 0.1% | 86 |
|
|
2019
Q3 | $1.07M | Sell |
39,023
-6,010
| -13% | -$165K | 0.18% | 81 |
|
|
2019
Q2 | $1.49M | Buy |
45,033
+420
| +0.9% | +$13.9K | 0.25% | 75 |
|
|
2019
Q1 | $1.56M | Buy |
44,613
+6,874
| +18% | +$241K | 0.27% | 75 |
|
|
2018
Q4 | $1.25M | Sell |
37,739
-3,891
| -9% | -$129K | 0.26% | 70 |
|
|
2018
Q3 | $2.1M | Buy |
+41,630
| New | +$2.1M | 0.38% | 62 |
|